Iovance Biotherapeutics
IOVA
IOVA
84 hedge funds and large institutions have $349M invested in Iovance Biotherapeutics in 2017 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 26 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less capital invested
Capital invested by funds: $361M → $349M (-$11.8M)
13% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 30
Holders
84
Holding in Top 10
3
Calls
$3.43M
Puts
$186K
Top Buyers
| 1 | +$8.01M | |
| 2 | +$5.85M | |
| 3 | +$3.06M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.24M |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$788K |
Top Sellers
| 1 | -$7.42M | |
| 2 | -$5.14M | |
| 3 | -$4.78M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$2.96M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$2.94M |